Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05903612
Status:
WITHDRAWN
Last Update Posted:
2024-01-16
First Post:
2023-06-06
Brief Title:
Allergic Bronchopulmonary Aspergillosis Prescreening Study
Sponsor:
Community Pharmacology Services Ltd
Organization:
Community Pharmacology Services Ltd
Study Overview
Official Title:
A Prescreening Study to Diagnose Allergic Bronchopulmonary Aspergillosis in Selected Patients With Asthma
Status:
WITHDRAWN
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Reasons unrelated to safety issues
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This prescreening study is being conducted to diagnose ABPA in selected patients with asthma and to increase the potential number of eligible participants for the ongoing Study 601-0018 of PUR1900 in subjects with ABPA See NCT05667662
Additionally this prescreening study may provide information that could assist the conduct of future studies conducted by Pulmatrix
Additionally this prescreening study may provide information that could assist the conduct of future studies conducted by Pulmatrix
Detailed Description:
See NCT05667662 for a detailed description fo the main ABPA study This prescreening study is designed to diagnose ABPA in patients with asthma to potentially increase the number of eligible participants for the ongoing NCT05667662 study This diagnosis will be confirmed through chest x-rays and a blood sample
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None